During deregulation talks in March, Clinton administration trade officials urged members of Japan’s Ministry of Health and Welfare in Tokyo to expedite the process by which American companies sell new and improved medical equipment.As part of last
During deregulation talks in March, Clinton administration trade officials urged members of Japans Ministry of Health and Welfare in Tokyo to expedite the process by which American companies sell new and improved medical equipment.
As part of last years U.S.-Japan deregulation agreement, Japan agreed to improve its approval and reimbursement system for new and existing medical technology.
Japan implemented some of the reforms, but not others, said Linda Ruckel, HIMA spokeswoman. In Marchs round of deregulation talks, HIMA urged Japanese officials to finish the remaining reforms.
Manufacturers of diagnostic imaging platforms such as MR, CT, and ultrasound enjoy success in Japan because hospitals can put out bids for equipment through a procurement process set up in the 1980s, said Paul Barry, HIMAs associate vice president of global strategy and analysis.
But if a U.S. company improves a heart catheter or any type of orthopedic or in vitro diagnostic equipment, the manufacturer must wait for Japans national health insurance system to create a new category for the equipment. The system is run by the Ministry of Health and Welfare.
Currently, new technology can be introduced in the Japanese market only on April 1 every two yearswith rare exceptions. The Japanese government will not provide reimbursement coverage for improved versions of existing medical technology for months or even years.
You might gain a safety approval, but no reimbursement, Barry said.
Japans trade policy affects medical equipment companies such as Johnson & Johnson, Boston Scientific, Medtronic, St. Jude, and Smith & Nephew, Barry said.
U.S. companies supply approximately 25% of the $23.4 billion in medical technologies used by the Japanese. By comparison, U.S. medical technology companies hold a 40% to 50% market share in other foreign countries, according to HIMA.
This ultimately hurts Japans patients and providers, who lack access to the latest medical innovations, said Pamela Bailey, HIMAs president.
A Victory for Radiology: New CMS Proposal Would Provide Coverage of CT Colonography in 2025
July 12th 2024In newly issued proposals addressing changes to coverage for Medicare services in 2025, the Centers for Medicare and Medicaid Services (CMS) announced its intent to provide coverage of computed tomography colonography (CTC) for Medicare beneficiaries in 2025.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.